Nuvectis Pharma, Inc. - COM (NVCT)

CUSIP: 67080T108

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COM
Total 13F shares
983,925
Share change
+129,168
Total reported value
$7,378,970
Price per share
$7.50
Number of holders
11
Value change
+$968,656
Number of buys
5
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 67080T108?
CUSIP 67080T108 identifies NVCT - Nuvectis Pharma, Inc. - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Nuvectis Pharma, Inc. - COM (NVCT) as of Q4 2022

As of 31 Dec 2022, Nuvectis Pharma, Inc. - COM (NVCT) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 983,925 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, VANGUARD GROUP INC, BALDWIN BROTHERS LLC/MA, GEODE CAPITAL MANAGEMENT, LLC, Virtu Financial LLC, STATE STREET CORP, BlackRock Inc., Tower Research Capital LLC (TRC), MORGAN STANLEY, and WELLS FARGO & COMPANY/MN. This page lists 11 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.